Cadence Neuroscience logo

Cadence Neuroscience Funding & Investors

Cadence Neuroscience is an early-stage company developing new medical device therapies for the treatment of epilepsy, central pain, and other neurological disorders. The company's core technology has been developed at Mayo Clinic and is under clinical evaluation. Its medical device therapies provide medical practitioners with a procedure that can be used to tailor brain stimulation therapy to each individual and enhance seizure control compared to currently used protocols. Cadence Neuroscience was established in 2017 and is headquartered in Redmond, Washington.

cadenceneuro.com

Total Amount Raised: $41,029,992

Cadence Neuroscience Funding Rounds

  • Series B

    $26,029,994

    Series B Investors

    Angelini Lumira Biosciences Fund
    JAZZ Venture Partners
    Mayo Clinic
    F-Prime Capital
    Angelini Ventures
    LivaNova
  • Series A

    $15,000,000

    Series A Investors

    JAZZ Venture Partners
    Mayo Clinic Ventures
Funding info provided by Diffbot.